Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23118662)

1.

Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin e therapy (omalizumab).

Elmallah MK, Hendeles L, Hamilton RG, Capen C, Schuler PM.

J Pediatr Pharmacol Ther. 2012 Jan;17(1):88-92. doi: 10.5863/1551-6776-17.1.88.

2.

Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab.

Collins J, Devos G, Hudes G, Rosenstreich D.

J Asthma Allergy. 2012;5:65-70. doi: 10.2147/JAA.S34579. Epub 2012 Nov 8.

3.

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).

Kanu A, Patel K.

Pediatr Pulmonol. 2008 Dec;43(12):1249-51. doi: 10.1002/ppul.20907.

PMID:
19009619
4.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Jat KR, Walia DK, Khairwa A.

Cochrane Database Syst Rev. 2013 Sep 17;9:CD010288. doi: 10.1002/14651858.CD010288.pub2. Review.

PMID:
24043500
5.

Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.

Lin RY, Sethi S, Bhargave GA.

J Asthma. 2010 Oct;47(8):942-5. doi: 10.3109/02770903.2010.491144.

PMID:
20831464
6.
7.
8.

Omalizumab for exacerbations of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Lebecque P, Leonard A, Argaz M, Godding V, Pilette C.

BMJ Case Rep. 2009;2009. pii: bcr07.2008.0379. doi: 10.1136/bcr.07.2008.0379. Epub 2009 Mar 5.

9.

Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.

Zicari AM, Celani C, De Castro G, Valerio De Biase R, Duse M.

Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1839-41.

10.

Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.

Tanou K, Zintzaras E, Kaditis AG.

Pediatr Pulmonol. 2014 May;49(5):503-7. doi: 10.1002/ppul.22937. Epub 2013 Oct 25. Review.

PMID:
24167019
11.

Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M.

Am J Respir Crit Care Med. 2006 Jun 15;173(12):1370-6. Epub 2006 Mar 16.

PMID:
16543550
12.

Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis.

Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG.

J Allergy Clin Immunol. 1994 May;93(5):926-31.

PMID:
8182235
13.
14.

Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Lehmann S, Pfannenstiel C, Friedrichs F, Kröger K, Wagner N, Tenbrock K.

Ther Adv Respir Dis. 2014 Oct;8(5):141-9. doi: 10.1177/1753465814547517. Epub 2014 Aug 21.

PMID:
25150265
15.

Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.

Voskamp AL, Gillman A, Symons K, Sandrini A, Rolland JM, O'Hehir RE, Douglass JA.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):192-9. doi: 10.1016/j.jaip.2014.12.008. Epub 2015 Jan 29.

PMID:
25640470
16.

Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.

Barton RC, Hobson RP, Denton M, Peckham D, Brownlee K, Conway S, Kerr MA.

Diagn Microbiol Infect Dis. 2008 Nov;62(3):287-91. doi: 10.1016/j.diagmicrobio.2008.06.018.

PMID:
18947811
17.

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.

Zirbes JM, Milla CE.

Pediatr Pulmonol. 2008 Jun;43(6):607-10. doi: 10.1002/ppul.20804.

PMID:
18433040
18.

Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.

Wong R, Wong M, Robinson PD, Fitzgerald DA.

Paediatr Respir Rev. 2013 Mar;14(1):22-4. doi: 10.1016/j.prrv.2012.11.004. Epub 2013 Jan 1.

PMID:
23287795
19.

Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis.

Chung Y, Kraut JR, Stone AM, Valaitis J.

Pediatr Pulmonol. 1994 Feb;17(2):131-4.

PMID:
8165040
20.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk